Compounds > phosphatidylcholines
Page last updated: 2024-09-05

phosphatidylcholines and Carcinoma, Basal Cell, Pigmented

phosphatidylcholines has been researched along with Carcinoma, Basal Cell, Pigmented in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borgan, E; Børresen-Dale, AL; Engebraaten, O; Gribbestad, IS; Huuse, EM; Lindholm, EM; Maelandsmo, GM; Moestue, SA; Sitter, B1
Givens, M; He, JL; Hsia, SL; Romagosa, R; Saap, L; Salvarrey, A; Taylor, JR1

Trials

1 trial(s) available for phosphatidylcholines and Carcinoma, Basal Cell, Pigmented

ArticleYear
A pilot study to evaluate the treatment of basal cell carcinoma with 5-fluorouracil using phosphatidyl choline as a transepidermal carrier.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2000, Volume: 26, Issue:4

    Topics: Administration, Topical; Carcinoma, Basal Cell; Double-Blind Method; Drug Carriers; Fluorouracil; Humans; Ointments; Phosphatidylcholines; Pilot Projects; Skin Neoplasms

2000

Other Studies

1 other study(ies) available for phosphatidylcholines and Carcinoma, Basal Cell, Pigmented

ArticleYear
Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models.
    BMC cancer, 2010, Aug-17, Volume: 10

    Topics: Animals; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Basal Cell; Female; Gene Expression Profiling; Humans; Metabolome; Mice; Oligonucleotide Array Sequence Analysis; Phosphatidylcholines; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Xenograft Model Antitumor Assays

2010